🇨🇦July 7, 2026·19h agoIndustry

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026

Publisher

Bausch Health (IR News)

Canada

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: Bausch Health (IR News)
Region: Canada
Scope: Industry
Published: July 7, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on ir.bauschhealth.com

Leave the platform to read the original full article on the publisher site.

Source: Bausch Health (IR News)

Scope: Industry

Open original article

Related coverage

More related coverage

Certara/3h ago

Cracking the code on NCA: how Pinnacle 21 helps de-risk PK analyses

Certara/7h ago

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

Hyman, Phelps & McNamara (FDA Law)/8h ago

Coming Soon: Proposed Rule to Remove “Adequate Provision” (and Ban DTC TV Ads?)

Vivani Medical/7h ago

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management